[go: up one dir, main page]

GB1040278A - Bacterial compositions for the regeneration of the intestinal microflora - Google Patents

Bacterial compositions for the regeneration of the intestinal microflora

Info

Publication number
GB1040278A
GB1040278A GB40635/63A GB4063563A GB1040278A GB 1040278 A GB1040278 A GB 1040278A GB 40635/63 A GB40635/63 A GB 40635/63A GB 4063563 A GB4063563 A GB 4063563A GB 1040278 A GB1040278 A GB 1040278A
Authority
GB
United Kingdom
Prior art keywords
strains
bacterial
resistant
antibiotics
pathogenic yeasts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB40635/63A
Inventor
Pierre Laboureur
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ANALYSES ET DE RECH S BIOLOG M
APPLIC BIOCHIMIQUES SOC ET
Original Assignee
ANALYSES ET DE RECH S BIOLOG M
APPLIC BIOCHIMIQUES SOC ET
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ANALYSES ET DE RECH S BIOLOG M, APPLIC BIOCHIMIQUES SOC ET filed Critical ANALYSES ET DE RECH S BIOLOG M
Priority to GB40635/63A priority Critical patent/GB1040278A/en
Priority to FR988365A priority patent/FR5373M/fr
Priority to BE653690D priority patent/BE653690A/xx
Priority to DE19641492135 priority patent/DE1492135A1/en
Publication of GB1040278A publication Critical patent/GB1040278A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

A bacterial composition for the regeneration of intestinal microflora comprises a balanced association of bacterial strains which are saprophytic microflora, combatant to pathogenic yeasts and resistant to antibiotics under the conditions within the human intestine; the bacterial association should preferably incorporate strains capable of secreting enzymes and capable of proliferating in the presence of bile products. The composition may comprise (i) a Lactobacillus strain such as L. brevis, L. bifidus or L. acidophilus, (ii) a Bacillus strain such as B. subtilis, B. mesentericus, B. pumilis or B. megatherium, and (iii) Aerobacter aerogenes, Escherichia coli, Escherichia interme dium or Pseudomonas fluorescens migula. A preferred bacterial composition includes 50-60% of Lactobacillus brevis buchneri, 20-30% Bacillus subtilis and 10-25% of Aerobacter aerogenes; equal proportions of the three stains may be employed. The strains may be rendered more resistant to antibiotics and to pathogenic yeasts by seeding to transplanting the strains through a series of culture media containing antibiotics (specified) or pathogenic yeasts (particularly Candida albicans). The strains should desirably be resistant to sulphamides (specified). Stated proportions of the bacterial compositions may be compounded in a pharmaceutical carrier.
GB40635/63A 1963-10-15 1963-10-15 Bacterial compositions for the regeneration of the intestinal microflora Expired GB1040278A (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
GB40635/63A GB1040278A (en) 1963-10-15 1963-10-15 Bacterial compositions for the regeneration of the intestinal microflora
FR988365A FR5373M (en) 1963-10-15 1964-09-17
BE653690D BE653690A (en) 1963-10-15 1964-09-29
DE19641492135 DE1492135A1 (en) 1963-10-15 1964-10-14 Process for the production of medicaments for the regeneration of the intestinal microflora

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB40635/63A GB1040278A (en) 1963-10-15 1963-10-15 Bacterial compositions for the regeneration of the intestinal microflora

Publications (1)

Publication Number Publication Date
GB1040278A true GB1040278A (en) 1966-08-24

Family

ID=10415870

Family Applications (1)

Application Number Title Priority Date Filing Date
GB40635/63A Expired GB1040278A (en) 1963-10-15 1963-10-15 Bacterial compositions for the regeneration of the intestinal microflora

Country Status (4)

Country Link
BE (1) BE653690A (en)
DE (1) DE1492135A1 (en)
FR (1) FR5373M (en)
GB (1) GB1040278A (en)

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2352058A1 (en) * 1976-05-21 1977-12-16 Seiken Kai Foundation NEW DEODORIZER AND ITS PREPARATION AND STORAGE PROCESS
FR2411889A1 (en) * 1977-12-15 1979-07-13 Bayer Ag NEW PREPARATIONS OF MICRO-ORGANISMS AND THEIR PRODUCTION PROCESS
WO1993013786A1 (en) * 1992-01-16 1993-07-22 Stephen Philip Mann Formulation and use of microorganisms in treating livestock
FR2723748A1 (en) * 1994-08-17 1996-02-23 Hoffmann La Roche New caledothricin antibiotics with antifungal activity
GB2318978A (en) * 1996-11-06 1998-05-13 Cultech Limited Recolonisation of intestinal tract with microflora
WO2000010582A2 (en) * 1998-08-24 2000-03-02 Ganeden Biotech, Inc. Probiotic, lactic acid-producing bacteria and uses thereof
US9446111B2 (en) 2009-04-29 2016-09-20 Ganeden Biotech, Inc. Inactivated bacterial cell formulation
US9622502B2 (en) 2008-10-16 2017-04-18 Ganeden Biotech, Inc. Probiotic Bacillus pasta compositions
US10111916B2 (en) 2003-12-05 2018-10-30 Ganeden Biotech, Inc. Compositions comprising Bacillus coagulans spores and whey
US10383342B2 (en) 2007-08-29 2019-08-20 Ganeden Biotech, Inc. Baked goods
US11235008B2 (en) 2011-03-31 2022-02-01 Ganeden Biotech, Inc. Probiotic sports nutrition compositions

Cited By (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2352058A1 (en) * 1976-05-21 1977-12-16 Seiken Kai Foundation NEW DEODORIZER AND ITS PREPARATION AND STORAGE PROCESS
US4879238A (en) * 1976-05-21 1989-11-07 Seikenkai Deodorant and method for preparing and storing same
FR2411889A1 (en) * 1977-12-15 1979-07-13 Bayer Ag NEW PREPARATIONS OF MICRO-ORGANISMS AND THEIR PRODUCTION PROCESS
WO1993013786A1 (en) * 1992-01-16 1993-07-22 Stephen Philip Mann Formulation and use of microorganisms in treating livestock
AU667070B2 (en) * 1992-01-16 1996-03-07 Stephen Philip Mann Formulation and use of microorganisms in treating livestock
US5718894A (en) * 1992-01-16 1998-02-17 Biotal Ltd. Formulation and use of microorganisms in treating livestock
FR2723748A1 (en) * 1994-08-17 1996-02-23 Hoffmann La Roche New caledothricin antibiotics with antifungal activity
GB2318978A (en) * 1996-11-06 1998-05-13 Cultech Limited Recolonisation of intestinal tract with microflora
US7708988B2 (en) 1998-08-24 2010-05-04 Ganeden Biotech, Incorporated Probiotic, lactic acid-producing bacteria and uses thereof
JP2002523372A (en) * 1998-08-24 2002-07-30 ガネデン バイオテック， インコーポレイテッド Symbiotic lactic acid producing bacteria and uses thereof
US6461607B1 (en) 1998-08-24 2002-10-08 Ganeden Biotech, Inc. Probiotic, lactic acid-producing bacteria and uses thereof
WO2000010582A2 (en) * 1998-08-24 2000-03-02 Ganeden Biotech, Inc. Probiotic, lactic acid-producing bacteria and uses thereof
US7807151B2 (en) 1998-08-24 2010-10-05 Ganeden Biotech, Incorporated Probiotic, lactic acid-producing bacteria and uses thereof
US8097247B2 (en) 1998-08-24 2012-01-17 Ganeden Biotech, Inc. Probiotic, lactic acid-producing bacteria and uses thereof
US8187590B2 (en) 1998-08-24 2012-05-29 Ganeden Biotech, Inc. Probiotic, lactic acid-producing bacteria and uses thereof
US8697055B2 (en) 1998-08-24 2014-04-15 Ganeden Biotech, Inc. Probiotic, lactic acid-producing bacteria
WO2000010582A3 (en) * 1998-08-24 2000-07-13 Ganeden Biotech Inc Probiotic, lactic acid-producing bacteria and uses thereof
US10111916B2 (en) 2003-12-05 2018-10-30 Ganeden Biotech, Inc. Compositions comprising Bacillus coagulans spores and whey
US10383342B2 (en) 2007-08-29 2019-08-20 Ganeden Biotech, Inc. Baked goods
US10321704B2 (en) 2008-10-16 2019-06-18 Ganeden Biotech, Inc. Probiotic grain-based compositions
US9622502B2 (en) 2008-10-16 2017-04-18 Ganeden Biotech, Inc. Probiotic Bacillus pasta compositions
US11419355B2 (en) 2008-10-16 2022-08-23 Ganeden Biotech, Inc. Probiotic grain-based compositions
US9757442B2 (en) 2009-04-29 2017-09-12 Ganeden Biotech, Inc. Inactivated bacterial cell formulation
US9446111B2 (en) 2009-04-29 2016-09-20 Ganeden Biotech, Inc. Inactivated bacterial cell formulation
US11235008B2 (en) 2011-03-31 2022-02-01 Ganeden Biotech, Inc. Probiotic sports nutrition compositions
US11351206B2 (en) 2011-03-31 2022-06-07 Ganeden Biotech, Inc. Probiotic sports nutrition compositions

Also Published As

Publication number Publication date
DE1492135A1 (en) 1969-06-12
FR5373M (en) 1967-09-18
BE653690A (en) 1965-01-18

Similar Documents

Publication Publication Date Title
Sands et al. Isolation of fluorescent pseudomonads with a selective medium
Mossel et al. Oxytetracycline‐glucose‐yeast extract agar for selective enumeration of moulds and yeasts in foods and clinical material
Stonier Agrobacterium tumefaciens Conn II: Production of an antibiotic substance
ES2234002T3 (en) POTENTIAL OF THE MICROBIAL COLONIZATION OF THE GASTROINTESTINAL TRACT.
GB1040278A (en) Bacterial compositions for the regeneration of the intestinal microflora
FI20012509A (en) New strains of Lactobacillus and their use in the production of food, in particular oatmeal
NO308617B1 (en) Culture of a lactic acid bacterium, mixture containing the culture and application of the culture
Paine Jr et al. Observations on bacteria sensitive to, resistant to, and dependent upon streptomycin
ES2084806T3 (en) PHARMACEUTICAL PREPARATION FOR THE CONTROL OF PATHOGENIC INTESTINAL BACTERIA.
RU95100750A (en) Strain bifidobacterium breve 79-119 used for preparing bacterial curative-prophylaxis bifidocontaining preparations
Gray et al. The use of potassium tellurite, sodium azide, and acetic acid in a selective medium for the isolation of Listeria monocytogenes
Morton et al. Isolation of pleuropneumonia-like organisms from human saliva: a newly detected member of the oral flora
MY129859A (en) Bacterial strains of the bacterium bacillus thuringiensis and uses therefor
Allansmith et al. Concomitance of bacteria in various areas of the eye
Rosenthal Studies in Chemotherapy: III. The Effect of p-Aminobenzene Sulphonamide on Pneumococci in Vitro
Krieg In vitro determination of Bacillus thuringiensis, Bacillus cereus, and related bacilli
GB1429229A (en) Antibiotics
GB1332002A (en) Microbial amylases and preparations thereof
Gorbach et al. Effect of bismuth subsalicylate on fecal microflora
KR100416192B1 (en) A New Strain of Bacillus megaterium PS352 Isolated from Soy Sediment and A Probiotic Usage of the Strain
Lees et al. Restriction and modification of bacteriophage in Bacillus stearothermophilus
Parker Paired culture interaction of the oral microbiota
Kulp A Note Concerning the Effect of a Specific Environment on the Characteristics and Viability of Several Strains of Aerobacter aerogenes and Escherichia coli
GB1313318A (en) Pharmaceutical preparation for the treatment of hemorrhoids
ES8104402A1 (en) Bacterial lysates